期刊文献+

基质金属蛋白酶9和基质金属蛋白酶组织抑制物1在不同性质胸腔积液诊断和鉴别诊断中的应用 被引量:3

Value of matrix metalioproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis and differential diagnosis of plenral effusion
原文传递
导出
摘要 目的探讨基质金属蛋白酶9(MMP-9)、基质金属蛋白酶组织抑制物1(TIMP-1)及MMP-9/TIMP-1比值在结核性和肿瘤性胸腔积液形成过程中的作用及在上述胸腔积液诊断和鉴别诊断中的价值。方法采用ELISA法测定36例结核性胸膜炎、38例恶性肿瘤和14例漏出液患者胸水中MMP-9和TIMP-1的浓度。结果①结核性胸腔积液组胸水中MMP-9浓度、TIMP-1浓度和MMP-9/TIMP—1比值均高于恶性胸腔积液组和漏出液组(P值均〈0.05),恶性胸腔积液组上述指标均高于漏出液组(P值均〈0.05)。②恶性胸水脱落细胞学检查阳性组MMP-9浓度、MMP-9/TIMP-1均高于细胞学检查阴性组(P值均〈0.05),TIMP-1浓度低于细胞学检查阴性组(P〈0.05)。③MMP-9和TIMP-1之间呈正相关(r=0.239,P=0.025);MMP-9、MMP-9/TIMP-1分别与胸水乳酸脱氢酶、腺苷脱氨酶、蛋白质、白细胞总数、淋巴细胞比例之间呈显著正相关(P值均〈0.01);MMP-9、MMP-9/TIMP—1分别与胸水葡萄糖、氯化物之间呈显著负相关(P值均〈0.01);TIMP-1与乳酸脱氢酶、腺苷脱氨酶、蛋白质、淋巴细胞比例之间呈显著正相关(P值均〈0.01)。④胸水中MMP-9、TIMP-1、MMP-9/TIMP-1比值在恶性胸腔积液诊断中的敏感性分别为63.2%、71.1%和65.8%,特异性分别为83.3%、63.9%和80.6%。采用胸水MMP-9和TIMP-1串联联合检测的敏感性和特异性分别为39.5%和91.7%,并联联合检测的敏感性和特异性分别为94.7%和55.6%。结论MMP-9和TIMP-1与结核性胸膜炎和恶性胸腔积液的形成密切相关,MMP-9/TIMP-1比例的失衡在此过程中扮演了重要角色,胸水MMP-9、TIMP-1及MMP-9/TIMP-1比值的检测有助于结核性胸膜炎和恶性肿瘤所致胸腔积液的鉴别诊断。 Objective To explore the role of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in the pathogenesis of tuberculous and tumorous pleural effusion,and to assess the value of MMP-9, TIMP-1 and MMP-9/TIMP-1 in the diagnosis and differential diagnosis of these two kinds of pleural effusion. Methods MMP-9 and TIMP-1 in the pleural fluid were detected by enzyme-linked immunosorbent assay in 36 patients with tuberculous pleuritis,38 patients with malignant tumor and 14 patients with transudates. Results ① MMP-9, TIMP-1 and MMP-9/TIMP-1 in tuberculous pleural effusion were higher than those in malignant pleural effusion and transudates (all P 〈0.05). MMP-9, TIMP-1 and MMP-9/TIMP-1 in malignant pleural effusion were higher than those in transudates(all P 〈0.05). ②MMP-9 and MMP-9/TIMP-1in malignant pleural effusion with positive cytological findings were higher than those with negative cytological findings(all P 〈0. 05) ,while TIMP-1 was lower in the former than that in the latter( P 0.05). ③MMP-9 positively correlated with TIMP-1 ( r = 0. 239, P = 0. 025). MMP-9 and MMP-9/ TIMP-1 positively correlated with lactate dehydrogenase, adenosine deaminase, protein, total white blood cells and lymphocyte ratio in pleural effusion(all P ~ 0.01), and negatively correlated with glucose and chloride in pleural effusion (all P 〈 0.01 ). TIMP-1 positively correlated with lactate dehydrogenase, adenosine deaminase, protein and lymphocyte ratio in pleural effusion(all P 〈0.01 ). ④ In diagnosing tumorous pleural effusion, the sensitivities of MMP-9, TIMP-1 and MMP-9/TIMP-1 were respectively 63. 2%, 71.1% and 65.8%0, the specificities were respectively 83.3 %, 63.9% and 80. 6%. However, in the diagnosing process, the sensitivity and specificity were 39.5% and 91.7% when MMP-9 and TIMP-1 were combined in a series way, 94.7% and 55.6% in a parallel way. Conclusions MMP-9 and TIMP-1 are closely related to the tuberculous and tumorous pleural effusion. MMP-9/TIMP-1 plays a great role in the pathogenesis of tuberculous and tumorous pleural effusion. Detection of MMP-9, TIMP-1 and MMP-9/TIMP-1 in pleural effusion contributes to the differential diagnosis of tuberculous pleurisy and malignant pleural effusion.
出处 《国际呼吸杂志》 2009年第22期1353-1357,共5页 International Journal of Respiration
基金 上海市闵行区自然科学基金资助项目(2008MH062)
关键词 肺肿瘤 结核 胸腔积液 基质金属蛋白酶9 基质金属蛋白酶组织抑制物1 Lung tumor Tuberculosis Pleural effusion Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献6

  • 1Braunschweig R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol, 2001,24 : 174-180.
  • 2Hurewitz AN, Zucker S, Mancuso P, et al. Human pleural effusions are rich in matrix metalloproteinases. Chest, 1992, 102 : 1808-1814.
  • 3Park K J, Hwang SC, Sheen SS, et al. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration, 2005,72 .. 166-175.
  • 4Iglesias D, Alegre J, Aleman C, et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J, 2005,25 : 104-109.
  • 5Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 2000,18 : 1135-1149.
  • 6Hoheisel G, Sack U, Hui DS, et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis, 2001,81 : 208-209.

同被引文献44

  • 1孙瑜,王良兴,王惠军,李翊卫.VEGF、CD44_(V6)、MMP联合检测对良、恶性胸水的鉴别意义[J].温州医学院学报,2006,36(4):350-353. 被引量:6
  • 2孙瑜,王惠军,李翊卫,王良兴.端粒酶 血管内皮生长因子 粘附分子 基质金属蛋白酶检测对胸腔积液性质鉴别的临床意义[J].中国实用内科杂志:临床前沿版,2006,26(12):1968-1970. 被引量:2
  • 3Hurewitz AN,Zucker S,Mancuso F,et al.Human pleural effusions are rich in matrix raetalloproteinases.Chest,1992,102,1808-1814.
  • 4Park KJ,Hwang SC,Sheen SS,et al.Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.Respiration,2005,72:166-175.
  • 5Iglesias D,Alegre J,Alemán C,et al.Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.Eur Respir J,2005,25:104-109.
  • 6Gross J,Lapiere CM.Collagenolytic activity in amphibian tissues:a tissue culture assay.Proc Natl Acad Sci U S A,1962,48:1014-1022.
  • 7Nelson AR,Fingleton B,Rothenberg ML,et al.Matrix metalloproteinases:biologic activity and clinical implications.J Clin Oncol,2000,18:1135-1149.
  • 8Hoekstra R,Eskens FA,Verweij J.Matrix metalloproteinase inhibitors:current developments and future perspectives.Oncologist,2001,6:415-427.
  • 9Eickelberg O,Sommerfeld CO,Wyser C,et all MMP and TIMP expression pattern in pleural effusions of different origins.Am J Respir Respir Crit Care Med,1997,156:1987-1992.
  • 10Jin HY,Lee KS,Jin SM,et al.Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.Respir Med,2004,98:115-122.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部